First Immune GcMAF

treatment for cancer, aids and immune diseases

  • Increase font size
  • Default font size
  • Decrease font size
Home Video: cancer cells destroyed Prof De Meirleir on GcMAF & CFS

Prof De Meirleir talks about GcMAF & treating CFS

Prof K De Meirleir talks at the Treating Autism 2012 Conference in Uxbridge (www.treatingautism.co.uk) about the similarities between the illnesses of ME/CFS and autism, together with the fact that patients with ME/CFS are 30 times more likely to have a child suffering from autism. Dr De Meirleir is well known in the medical profession for his treatment of ME/CFS, a firm advocate of the power of GcMAF and describes the rationale behind GcMAF therapy. His sister Linda De Meirleir is a Professor of Pediatric Neurology in Brussels and is replicating the work done by Dr Bradstreet in treating autism with First Immune GcMAF.

Prof De Meirleir describes the use of GcMAF in treating CFS and autism at the Treating Autism Conference 9th September 2012 (1 of 2)

Prof De Meirleir describes the use of GcMAF in treating CFS and autism at the Treating Autism Conference 9th September 2012 (2 of 2)

Dr Jeff Bradstreet in First Immune GcMAF's laboratory

Dr Bradstreet visits First Immune GcMAF's laboratory to inspect for quality control. He has now treated over 900 autistic patients using First Immune GcMAF, ranging from less than a year old to almost 40 years old. In addition, he treats cancer, ME/CFS and a broad range of disorders with GcMAF. Describing First Immune's laboratory as a boutique laboratory, he explains that this treatment is accessible to all, thanks to gcmaf.eu. He descibes his experience of the lab as top quality, excellent scientists producing a product that is pure, sterile and above all, active.